KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Shares Issued (2016 - 2022)

Thermo Fisher Scientific filings provide 14 years of Shares Issued readings, the most recent being $6.0 million for Q4 2022.

  • On a quarterly basis, Shares Issued fell 79.31% to $6.0 million in Q4 2022 year-over-year; TTM through Oct 2022 was $112.0 million, a 20.57% decrease, with the full-year FY2021 number at $156.0 million, down 20.41% from a year prior.
  • Shares Issued hit $6.0 million in Q4 2022 for Thermo Fisher Scientific, down from $49.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $81.0 million in Q1 2019 to a low of -$7.0 million in Q3 2019.
  • Median Shares Issued over the past 5 years was $39.0 million (2018), compared with a mean of $36.7 million.
  • Biggest five-year swings in Shares Issued: plummeted 136.84% in 2019 and later soared 542.86% in 2020.
  • Thermo Fisher Scientific's Shares Issued stood at $39.0 million in 2018, then fell by 2.56% to $38.0 million in 2019, then rose by 5.26% to $40.0 million in 2020, then soared by 37.5% to $55.0 million in 2021, then crashed by 89.09% to $6.0 million in 2022.
  • The last three reported values for Shares Issued were $6.0 million (Q4 2022), $49.0 million (Q3 2022), and $2.0 million (Q2 2022) per Business Quant data.